Dual neutralisation of interleukin-17A and interleukin-17F...

Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study

van der Heijde, Désirée, Gensler, Lianne S, Deodhar, Atul, Baraliakos, Xenofon, Poddubnyy, Denis, Kivitz, Alan, Farmer, Mary Katherine, Baeten, Dominique, Goldammer, Nadine, Coarse, Jason, Oortgiese
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
79
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2020-216980
Date:
May, 2020
File:
PDF, 1.47 MB
2020
Conversion to is in progress
Conversion to is failed